The ROSALINE Trial is a Phase 2 pre-operative study for people with early-stage invasive lobular carcinoma (ILC), also know as lobular breast cancer. Name of […]
ROSALINE Trial for Patients with Early-Stage Lobular Breast Cancer Read More »
Postmenopausal women who have been diagnosed with invasive lobular breast cancer (ILC) who have not yet had surgery to remove their tumor may be eligible to participate in a multi-site clinical trial. This clinical trial will compare how lobular breast tumors respond to three different commonly prescribed, effective medications that are currently being used to treat breast cancer.Â
Clinical Trial: Endocrine Response in Pre-Surgical ILC Patients Read More »
The ROLO trial is a targeted therapy clinical trial in the United Kingdom for patients with advanced or metastatic lobular breast cancer. Name of the
ROLO: Targeted Therapy Trial for Advanced ILC Read More »
The GELATO clinical trial was a lobular breast-cancer specific immunotherapy trial investigating the response to an immunotherapy + chemotherapy medication combination. This phase 2 trial
GELATO: Immunotherapy Clinical Trial for ILC Mets Read More »
Women who have been diagnosed with Stage 1 – 3 invasive lobular breast cancer (ILC) who have not yet had surgery to remove their tumor may be eligible to participate in a clinical trial. This trial is open to all ER+ and/or PR+ HER2- patients (ductal or lobular), however it is being enriched with lobular breast cancer patients to promote a better understanding of how ILC might respond differently to these therapies.
PELOPS: Clinical Trial with Palbociclib for Pre-surgical ILC Patients Read More »
"*" indicates required fields